Zamubafusp alfa

DB32269InvestigationalProtein Based Therapies

Zamubafusp alfa is an immunoglobulin-peptide fusion protein. It consists of a humanized IgG1 and p5R which is a pan-amyloid reactive peptide.

Mechanism
Curator reviewed
Code names
AT-02

Resolves to

Compound
UNII32PJN9JE4ACAS2937458-25-6

What you can answer from here — as of August 29, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Zamubafusp alfa, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In